Sonodynamic therapy (SDT) is a promising non-invasive therapeutic modality, which provides many opportunities and benefits, including deeper tissue penetration, high precision, less side effects, and good patient compliance. Ultrasound stimulated therapies could offer an alternative to these treatments with their increased efficiency, greater penetration depth, and reduced side effects. Therefore, SDT is becoming a more and more popular field and direction for research and experiment because many existing cancer treatment strategies cause systemic toxicity or cannot penetrate tissue deep enough to reach the entire tumor.
LIPUSTIM® 300 Series Sonodynamic Therapy System
is an integrated low-intensity pulsed ultrasound (LIPUS) system for ultrasound-assisted scientific research and experiments. LIPUSTIM is composed by a built-in generator, a compensating amplifier and a set of transducers designated for in-vivo, ex-vivo and in-vitro experiments. LIPUSTIM®
offers comprehensive ultrasound solutions for a variety fields of scientific research, including drug delivery, gene delivery, treatments for cancerous tumor, bone fracture and tissue recovery, and osteoarthritic cartilage regeneration. The 144 standard combinations of frequency and intensity settings offered by LIPUSTIM®
open up the possibility to rationally optimize SDT with the ultimate goal to bring this treatment modality to the clinics.